BMRN
Biomarin Pharmaceutical
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: BMRN
- PEG Ratio
BMRN's PE to growth ratio is not computable because the earnings growth data is negative or zero. Biomarin Pharmaceutical last had a PEG ratio of 0.33 in September 2025.
BMRN PEG ratio history
A seven years lookback reveals an average PEG ratio of 0.93 for Biomarin Pharmaceutical. Within the past seven years, the Dec 2023 quarter saw the highest PEG reading at 6.34. At 0, the Dec 2020 quarter represented the lowest PEG ratio in this timeframe.
Biomarin Pharmaceutical PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | 32.65 | -19.1% |
| 2024 | 0.19 | 29.21 | 152.8% |
| 2023 | 6.34 | 108.34 | 17.1% |
| 2022 | 0.43 | 136.17 | 317.1% |
| 2021 | N/A | N/A | -107.4% |
| 2020 | 0 | 18.58 | 3,730.8% |
| 2019 | N/A | N/A | 70.5% |
| 2018 | N/A | N/A | 34.3% |
| 2017 | N/A | N/A | 82.4% |
| 2016 | N/A | N/A | -255.1% |
| 2015 | N/A | N/A | -16.3% |
| 2014 | N/A | N/A | 28.1% |
| 2013 | N/A | N/A | -34.7% |
| 2012 | N/A | N/A | -97.9% |
| 2011 | N/A | N/A | -124% |
Biomarin Pharmaceutical PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | 40.35 | -49.1% |
| Dec 2025 | N/A | 32.65 | -19.1% |
| Sep 2025 | 0.33 | 19.91 | 60% |
| Jun 2025 | 0.1 | 15.98 | 154.8% |
| Mar 2025 | 0.17 | 25.71 | 152.3% |
| Dec 2024 | 0.19 | 29.21 | 152.8% |
| Sep 2024 | 0.34 | 41.35 | 120.8% |
| Jun 2024 | 0.38 | 60.99 | 159.6% |
| Mar 2024 | 0.41 | 80.13 | 194.6% |
| Dec 2023 | 6.34 | 108.34 | 17.1% |
| Sep 2023 | 1.62 | 114.91 | 71.1% |
| Jun 2023 | 2.1 | 166.69 | 79.3% |
| Mar 2023 | 3.45 | 262.81 | 76.2% |
| Dec 2022 | 0.43 | 136.17 | 317.1% |
| Sep 2022 | 0.29 | 188.38 | 650% |
BMRN average PEG ratio chart
PEG comparison
BMRN EPS growth
BMRN Price vs fair value
BMRN PEG vs peers
| Stock name | PEG ratio | Market cap |
|---|---|---|
| CPRX Catalyst Pharmaceuticals Inc | 1.79 | $3.84B |
| RARE Ultragenyx Pharmaceutical Inc | N/A | $2.83B |
| ESPR Esperion Therapeutics Inc | N/A | $813.48M |
| BMRN Biomarin Pharmaceutical Inc | N/A | $10.92B |
Frequently asked questions
What is Biomarin Pharmaceutical's PEG ratio?
BMRN's PEG ratio cannot be computed because EPS growth data is negative or not present.
What is the 3-year average PEG ratio for Biomarin Pharmaceutical (BMRN)?
BMRN has a 3-year average PEG ratio of 1.2.
What is the 5-year average PEG ratio for Biomarin Pharmaceutical (BMRN)?
BMRN has a 5-year average PEG ratio of 1.16.
What is the highest PEG ratio for BMRN?
In the last seven years, BMRN's peak PEG ratio of 6.34 occurred in the Dec 2023 quarter.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.